Literature DB >> 9843812

Characterization of cardiac malonyl-CoA decarboxylase and its putative role in regulating fatty acid oxidation.

J R Dyck1, A J Barr, R L Barr, P E Kolattukudy, G D Lopaschuk.   

Abstract

Malonyl-CoA is a potent inhibitor of fatty acid uptake into the mitochondria. Although the synthesis of malonyl-CoA in the heart by acetyl-CoA carboxylase (ACC) has been well characterized, no information is available as to how malonyl-CoA is degraded. We demonstrate that malonyl-CoA decarboxylase (MCD) activity is present in the heart. Partial purification revealed a protein of approximately 50 kDa. The role of MCD in regulating fatty acid oxidation was also studied using isolated, perfused hearts from newborn rabbits and adult rats. Fatty acid oxidation in rabbit hearts increased dramatically between 1 day and 7 days after birth, which was accompanied by a decrease in both ACC activity and malonyl-CoA levels and a parallel increase in MCD activity. When adult rat hearts were aerobically reperfused after a 30-min period of no-flow ischemia, levels of malonyl-CoA decreased dramatically, which was accompanied by a decrease in ACC activity, a maintained MCD activity, and an increase in fatty acid oxidation rates. Taken together, our data suggest that the heart has an active MCD that has an important role in regulating fatty acid oxidation rates.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9843812     DOI: 10.1152/ajpheart.1998.275.6.H2122

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  27 in total

Review 1.  The malonyl-CoA-long-chain acyl-CoA axis in the maintenance of mammalian cell function.

Authors:  V A Zammit
Journal:  Biochem J       Date:  1999-11-01       Impact factor: 3.857

2.  Cloning and expression of rat pancreatic beta-cell malonyl-CoA decarboxylase.

Authors:  N Voilley; R Roduit; R Vicaretti; C Bonny; G Waeber; J R Dyck; G D Lopaschuk; M Prentki
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

Review 3.  Metabolic alterations induce oxidative stress in diabetic and failing hearts: different pathways, same outcome.

Authors:  David Roul; Fabio A Recchia
Journal:  Antioxid Redox Signal       Date:  2015-04-30       Impact factor: 8.401

4.  Tolerance to ischaemic injury in remodelled mouse hearts: less ischaemic glycogenolysis and preserved metabolic efficiency.

Authors:  Waleed G T Masoud; Osama Abo Al-Rob; Yang Yang; Gary D Lopaschuk; Alexander S Clanachan
Journal:  Cardiovasc Res       Date:  2015-07-06       Impact factor: 10.787

Review 5.  Modulating fatty acid oxidation in heart failure.

Authors:  Vincenzo Lionetti; William C Stanley; Fabio A Recchia
Journal:  Cardiovasc Res       Date:  2011-02-02       Impact factor: 10.787

6.  Ablation of LKB1 in the heart leads to energy deprivation and impaired cardiac function.

Authors:  Niels Jessen; Ho-Jin Koh; Clifford D Folmes; Cory Wagg; Nobuharu Fujii; Bo Løfgren; Cordula M Wolf; Charles I Berul; Michael F Hirshman; Gary D Lopaschuk; Laurie J Goodyear
Journal:  Biochim Biophys Acta       Date:  2010-05-02

Review 7.  Metabolic abnormalities in the diabetic heart.

Authors:  Gary D Lopaschuk
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

8.  Leptin activates hypothalamic acetyl-CoA carboxylase to inhibit food intake.

Authors:  Su Gao; Kimberly P Kinzig; Susan Aja; Karen A Scott; Wendy Keung; Sandra Kelly; Ken Strynadka; Shigeru Chohnan; Wanli W Smith; Kellie L K Tamashiro; Ellen E Ladenheim; Gabriele V Ronnett; Yajun Tu; Morris J Birnbaum; Gary D Lopaschuk; Timothy H Moran
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-23       Impact factor: 11.205

9.  Metabolic effects of glutamine on the heart: anaplerosis versus the hexosamine biosynthetic pathway.

Authors:  Benjamin Lauzier; Fanny Vaillant; Clemence Merlen; Roselle Gélinas; Bertrand Bouchard; Marie-Eve Rivard; Francois Labarthe; Vern W Dolinsky; Jason R B Dyck; Bruce G Allen; John C Chatham; Christine Des Rosiers
Journal:  J Mol Cell Cardiol       Date:  2012-11-28       Impact factor: 5.000

10.  Acetylation contributes to hypertrophy-caused maturational delay of cardiac energy metabolism.

Authors:  Arata Fukushima; Liyan Zhang; Alda Huqi; Victoria H Lam; Sonia Rawat; Tariq Altamimi; Cory S Wagg; Khushmol K Dhaliwal; Lisa K Hornberger; Paul F Kantor; Ivan M Rebeyka; Gary D Lopaschuk
Journal:  JCI Insight       Date:  2018-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.